{"product_id":"code-to-cure-digital-therapeutics-and-the-future-of-pharma-paperback","title":"Code to Cure: Digital Therapeutics and the Future of Pharma - Paperback","description":"\u003cdiv\u003e\u003cp style=\"text-align: right;\"\u003e\u003ca href=\"https:\/\/reportcopyrightinfringement.com\/\" target=\"_blank\" rel=\"nofollow\"\u003e\u003cb\u003eReport copyright infringement\u003c\/b\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/div\u003e\u003cp\u003eby \u003cb\u003eSubba Rao Chaganti\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\u003cp\u003eWhen medicine is written in code, how do you market the cure?\u003c\/p\u003e\u003cp\u003eA quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?\u003c\/p\u003e\u003cp\u003eIn Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.\u003c\/p\u003e\u003cp\u003eBlending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx: \u003c\/p\u003e\u003cp\u003e- What digital therapeutics are - and how they differ from wellness apps.\u003c\/p\u003e\u003cp\u003e- Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.\u003c\/p\u003e\u003cp\u003e- How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.\u003c\/p\u003e\u003cp\u003e- Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.\u003c\/p\u003e\u003cp\u003e- The role of AI, wearables, and telemedicine in scaling digital care.\u003c\/p\u003e\u003cp\u003e- Strategic frameworks for commercialization, adoption, and measuring success.\u003c\/p\u003e\u003cp\u003eWhether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.\u003c\/p\u003e\u003cp\u003eEngaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself.\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 208\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.44 x 9 x 6 IN\u003c\/div\u003e\n            \u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e February 01, 2026\u003c\/div\u003e\n            ","brand":"BooksCloud","offers":[{"title":"Default Title","offer_id":54089447014707,"sku":"9789347311147","price":46.24,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0300\/5595\/6612\/files\/NYf6K6RSTr9789347311147.webp?v=1789591888","url":"https:\/\/www.vysn.com\/products\/code-to-cure-digital-therapeutics-and-the-future-of-pharma-paperback","provider":"VYSN","version":"1.0","type":"link"}